anurajms/meta_analysis huggingface dataset:
outcomes:
Kinship care for the safety, permanency, and well‐being of children removed from the home for maltreatment
1. Problem Behavior
outcomes:
Fundoplication versus postoperative medication for gastro‐oesophageal reflux in children with neurological impairment undergoing gastrostomy
1. Gastroesophageal Reflux Disease
outcomes:
Gastrostomy feeding versus oral feeding alone for children with cerebral palsy
1. Lower Respiratory Tract Infection 2. Feeding Finding 3. Surgical complication 4. Vomiting 5. Body weight 6. Death 7. Seizure 8. Height Increased 9. Functional ability 10. Feeding Tube Complication 11. Nutritional status
outcomes:
Psychoanalytic/psychodynamic psychotherapy for children and adolescents who have been sexually abused
1. Self-harm 2. Aggressive Behavior 3. Posttraumatic Stress Disorder 4. Depression 5. Sexualized Behavior 6. Suicide
outcomes:
Specially formulated foods for treating children with moderate acute malnutrition in low‐ and middle‐income countries
1. Severe Acute Malnutrition 2. Withdrawn From Research Study 3. General Finding Of Height 4. Vomiting 5. Diarrhoea 6. Death Of Child 7. Weight Gain 8. Height and growth measurements 9. Mid-upper arm circumference
outcomes:
Specialist home‐based nursing services for children with acute and chronic illnesses
1. Mental Health Assessment Status 2. General Physical Condition 3. Hospitalization
outcomes:
Parent‐mediated early intervention for young children with autism spectrum disorders (ASD)
1. Social Interaction 2. Communication skills 3. Speech And Language Development Finding 4. Stress
outcomes:
Day 5 versus day 3 embryo biopsy for preimplantation genetic testing for monogenic/single gene defects
1. Live Birth 2. Miscarriage
outcomes:
Impact of the diagnostic test Xpert MTB/RIF on patient outcomes for tuberculosis
1. All Cause Mortality 2. Tuberculosis 3. Microbiologic Culture Positive 4. General Treatment
outcomes:
Adenoidectomy for otitis media with effusion (OME) in children
1. Hearing 2. Quality of Life 3. Haemorrhage
outcomes:
Pharmacological interventions for prophylaxis of vestibular migraine
1. Headache 2. Serious Adverse Event 3. Migraine 4. Vertigo 5. Health-Related Quality of Life
outcomes:
Pharmacological interventions for acute attacks of vestibular migraine
1. Serious Adverse Event 2. Vertigo
outcomes:
Non‐pharmacological interventions for prophylaxis of vestibular migraine
1. Headache 2. Serious Adverse Event 3. Migraine 4. Health-Related Quality of Life 5. Vertigo
outcomes:
Pharmacological interventions for persistent postural‐perceptual dizziness (PPPD)
1. Vestibular System Finding 2. Serious Adverse Event
outcomes:
Intratympanic corticosteroids for Ménière’s disease
1. Hearing 2. Serious Adverse Event 3. Tinnitus 4. Vertigo 5. Health-Related Quality of Life
outcomes:
Intratympanic gentamicin for Ménière’s disease
1. Hearing 2. Serious Adverse Event 3. Tinnitus 4. Vertigo
outcomes:
Lifestyle and dietary interventions for Ménière’s disease
1. Hearing 2. Serious Adverse Event 3. Tinnitus 4. Vertigo 5. Health-Related Quality of Life
outcomes:
Surgical interventions for Ménière’s disease
1. Hearing 2. Serious Adverse Event 3. Tinnitus 4. Vertigo 5. Health-Related Quality of Life
outcomes:
Systemic pharmacological interventions for Ménière’s disease
1. Hearing 2. Serious Adverse Event 3. Quality of Life 4. Tinnitus 5. Vertigo
outcomes:
Positive pressure therapy for Ménière’s disease
1. Hearing 2. Serious Adverse Event 3. Tinnitus 4. Adverse Event 5. Vertigo
outcomes:
Tranexamic acid for the reduction of bleeding during functional endoscopic sinus surgery
1. Intraoperative Hemorrhage 2. Haemorrhage 3. Adverse Event
outcomes:
Antihistamines for motion sickness
1. Motion Sickness
outcomes:
Interventions for the prevention of persistent post‐COVID‐19 olfactory dysfunction
1. Serious Adverse Event 2. Sense of smell 3. Quality of Life
outcomes:
Interventions for the treatment of persistent post‐COVID‐19 olfactory dysfunction
1. Serious Adverse Event 2. Sense of smell 3. Quality of Life
outcomes:
Intratympanic corticosteroids for sudden sensorineural hearing loss
1. Adverse Event 2. Hearing threshold
outcomes:
Medical interventions for chronic rhinosinusitis in cystic fibrosis
1. Recurrent Sinusitis 2. Serious Adverse Event 3. Chronic Rhinosinusitis 4. Quality of Life 5. Adverse Event
outcomes:
Biologics for chronic rhinosinusitis
1. Nasal Obstruction 2. Apparent Life-threatening Event 3. Chronic Rhinosinusitis 4. Nasal Discharge 5. Anosmia 6. Visual Analog Scale 7. Hospitalization 8. Nasal Congestion 9. Nasopharyngitis 10. Able To Perform All Activities Of Daily Living 11. Cough 12. Health-Related Quality of Life 13. Computerised Tomography 14. Rhinorrhea 15. Serious Adverse Event 16. Facial Pain 17. Surgery 18. Death
outcomes:
Efficacy and safety of rapid tests to guide antibiotic prescriptions for sore throat
1. Systemic Antibacterial Therapy 2. Follow-up Consultation 3. Complication
outcomes:
Cognitive behavioural therapy for tinnitus
1. Quality of Life 2. Depression 3. Anxiety 4. Tinnitus 5. Functional Status Index 6. Suicidal Behavior 7. Health-Related Quality of Life
outcomes:
Tranexamic acid for patients with nasal haemorrhage (epistaxis)
1. Epistaxis 2. Serious Adverse Event 3. Length Of Stay 4. Seizure 5. Thromboembolic Event
outcomes:
Sound therapy (using amplification devices and/or sound generators) for tinnitus
1. Complication Associated With Device 2. Depressive symptoms 3. Depression 4. Tinnitus 5. Generalized Anxiety Disorder 6. Anxiety Symptoms 7. Tinnitus Loudness Match 8. Health-Related Quality of Life
outcomes:
Antibiotics for acute rhinosinusitis in adults
1. Adverse Drug Reaction 2. Treatment Failure 3. Purulent Rhinitis 4. Clinical Resolution 5. Diarrhoea 6. Acute Rhinosinusitis
outcomes:
Perioperative local anaesthesia for reducing pain following septal surgery
1. Postoperative Hemorrhage 2. Analgesia 3. Postoperative Pain 4. Visual Analog Scale 5. Postoperative Vomiting 6. Hospitalization 7. Pain Intensity
outcomes:
Bilateral versus unilateral hearing aids for bilateral hearing impairment in adults
1. Ear Infection 2. Localization Of Sound Source 3. Hearing Finding 4. Hearing 5. Hearing Aid Worn 6. Quality of Life 7. Communication Disorder 8. Earache 9. Adverse Event
outcomes:
Influenza vaccines for preventing acute otitis media in infants and children
1. Rhinorrhea 2. Pharyngitis 3. Acute Otitis Media 4. Fever 5. Antibiotic Therapy
outcomes:
Hearing aids for mild to moderate hearing loss in adults
1. Ear Infection 2. Quality Of Life Decreased 3. Hearing 4. Pain 5. Noise-induced Hearing Loss 6. Skin Irritation
outcomes:
Heated, humidified air for the common cold
1. Treatment Failure 2. Culture Positive 3. Clinical Improvement
outcomes:
Coblation versus other surgical techniques for tonsillectomy
1. Postoperative Hemorrhage 2. Postoperative Pain 3. Intraoperative Hemorrhage 4. Adverse Event
outcomes:
Needle aspiration versus incision and drainage for the treatment of peritonsillar abscess
1. Pain 2. Disease Recurrence 3. Normal diet 4. Procedural Pain 5. Adverse Event 6. Peritonsillar Abscess
outcomes:
Interventions for children with ear discharge occurring at least two weeks following grommet (ventilation tube) insertion
1. Acute Mastoiditis 2. Hearing Finding 3. Device Extrusion 4. Adverse Event 5. Fever 6. Audiometric Test 7. Otorrhea 8. Gastrointestinal Symptom 9. Hearing 10. Disease Recurrence 11. Quality of Life 12. Acute Mastoiditis With Intracranial Complication 13. Complication 14. Ventilation Tube In Tympanic Membrane 15. Otitis Media 16. Device Blockage 17. Skin Rash 18. Earache 19. Ototoxicity
outcomes:
Nasal decongestants in monotherapy for the common cold
1. General well-being 2. Nasal Congestion 3. Adverse Event 4. Patient-Reported Outcome
outcomes:
Interventions to improve hearing aid use in adult auditory rehabilitation
1. Quality Of Life Decreased 2. Hearing Improved 3. Communication skills 4. Hearing Aid Worn 5. Hearing impairment 6. Complaint 7. Hearing Aid Wearer 8. Adverse Event
outcomes:
Betahistine for symptoms of vertigo
1. Gastrointestinal findings 2. Adverse Event 3. Vertigo
outcomes:
Antibiotics for otitis media with effusion in children
1. Otitis Media with Effusion 2. Vomiting 3. Diarrhoea 4. Ventilation Tube In Tympanic Membrane 5. Adverse Event 6. Skin Rash 7. Tympanic Membrane
outcomes:
Short‐course oral steroids as an adjunct therapy for chronic rhinosinusitis
1. Nasal Obstruction 2. Mood disturbance 3. Chronic Rhinosinusitis 4. Anosmia 5. Nasal Congestion 6. Adverse Event 7. Cough 8. Rhinorrhea 9. Insomnia 10. Facial Pain 11. Quality of Life 12. Abnormal Digestive Tract Function 13. Disturbance In Social Behaviour 14. Polyps Nasal
outcomes:
Different types of intranasal steroids for chronic rhinosinusitis
1. Nasal Obstruction 2. Chronic Rhinosinusitis 3. Anosmia 4. Visual Analog Scale 5. Nasal Congestion 6. Candidiasis Of Mouth 7. Cough 8. Rhinorrhea 9. Epistaxis 10. Sore Throat 11. Facial Pain 12. Irritation Symptom 13. Nose 14. Quality of Life 15. Polyps Nasal
outcomes:
Saline irrigation for chronic rhinosinusitis
1. Headache 2. Nasal Obstruction 3. Rhinitis 4. Chronic Rhinosinusitis 5. Anosmia 6. Nasal Discharge 7. Nasal Congestion 8. Cough 9. Quality Of Life Decreased 10. Rhinorrhea 11. Epistaxis 12. Nasal Burning 13. Facial Pain 14. Nasal Sinus Drainage 15. Epiphora 16. Polyps Nasal
outcomes:
Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis
1. Nasal Obstruction 2. Nasal Polyp 3. Chronic Rhinosinusitis 4. Anosmia 5. Throat Irritation 6. Candidiasis Of Mouth 7. Epistaxis 8. Rhinorrhea 9. Facial Pain 10. Irritation Symptom 11. Nose 12. Quality of Life 13. Polyps Nasal
outcomes:
Short‐course oral steroids alone for chronic rhinosinusitis
1. Rhinorrhea 2. Nasal Obstruction 3. Mood disturbance 4. Facial Pain 5. Insomnia 6. Nasal Polyp 7. Chronic Rhinosinusitis 8. Quality of Life 9. Anosmia 10. Nasal Discharge 11. Nasal Congestion 12. Cough
outcomes:
Systemic and topical antibiotics for chronic rhinosinusitis
1. Nasal Obstruction 2. Allergic Reaction 3. Chronic Rhinosinusitis 4. Anosmia 5. Nasal Discharge 6. Nausea 7. Abdominal Pain 8. Nasal Congestion 9. Cough 10. Rhinorrhea 11. Anaphylaxis 12. Vomiting 13. Gastrointestinal findings 14. Facial Pain 15. Quality of Life 16. Diarrhoea 17. Skin Irritation 18. Skin Rash 19. Polyps Nasal
outcomes:
Water precautions for prevention of infection in children with ventilation tubes (grommets)
1. Adverse Event 2. Otorrhea
outcomes:
Antihistamines for the common cold
1. Duration of Symptom 2. Common Cold
outcomes:
Corticosteroids for the common cold
1. Clinical Resolution 2. Time-to-Event 3. Clinical Improvement
outcomes:
Non‐steroidal anti‐inflammatory drugs for the common cold
1. Rhinorrhea 2. Headache 3. Duration of Symptom 4. Joint Pain 5. Throat Irritation 6. Muscle Pain 7. Common Cold 8. Global Assessment 9. Cough
outcomes:
Virtual reality training for improving the skills needed for performing surgery of the ear, nose or throat
1. Patient knowledge 2. Surgery 3. Psychomotor Skill Training
outcomes:
Antibiotics for preventing recurrent sore throat
1. Sore Throat 2. Rash 3. Candidiasis 4. Disease Recurrence 5. Diarrhea 6. Nausea 7. Adverse Event
outcomes:
Topical nasal steroids for treating nasal polyposis in people with cystic fibrosis
1. Nasal Symptom 2. Quality of Life
outcomes:
Pharmacological agents for the prevention of vestibular migraine
1. Migrainous Vertigo
outcomes:
Steroid‐eluting sinus stents for improving symptoms in chronic rhinosinusitis patients undergoing functional endoscopic sinus surgery
1. Chronic Rhinosinusitis 2. Clinical Improvement
outcomes:
Antibiotics for acute laryngitis in adults
1. Voice Finding 2. Clinical Cure 3. Clinical Improvement 4. Laryngitis
outcomes:
Vestibular rehabilitation for unilateral peripheral vestibular dysfunction
1. Dizziness 2. Dysfunction Of Vestibular System 3. Rehabilitation Therapy 4. Disease Recurrence
outcomes:
Stereotactic radiotherapy for vestibular schwannoma
1. Hearing impairment 2. Impairment Of Balance 3. Facial Palsy 4. Tinnitus 5. Acoustic Neuroma
outcomes:
The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigo
1. Vertigo
outcomes:
Surgical versus medical interventions for chronic rhinosinusitis with nasal polyps
1. Nasal Symptom 2. Endoscopy Finding 3. Nasal Obstruction 4. Chronic Rhinosinusitis 5. Quality of Life 6. Olfactory test 7. Complication 8. Blocked Sinuses 9. Polyps Nasal
outcomes:
Over‐the‐counter (OTC) medications for acute cough in children and adults in community settings
1. Acute Cough
outcomes:
Surgical interventions for chronic rhinosinusitis with nasal polyps
1. Nasal Symptom 2. Nasal Obstruction 3. Nasal Polyp 4. Chronic Rhinosinusitis 5. Quality of Life 6. Polyps Nasal
outcomes:
Tonsillectomy or adenotonsillectomy versus non‐surgical treatment for chronic/recurrent acute tonsillitis
1. Tonsillitis 2. Sore Throat 3. Quality of Life 4. Death 5. Complication 6. Able To Perform All Activities Of Daily Living
outcomes:
Amplification with hearing aids for patients with tinnitus and co‐existing hearing loss
1. Quality of Life 2. Depression 3. Anxiety 4. Tinnitus 5. Adverse Event 6. Difficulty Coping
outcomes:
Once or twice daily versus three times daily amoxicillin with or without clavulanate for the treatment of acute otitis media
1. Clinical Resolution
outcomes:
Nebulized epinephrine for croup in children
1. Croup
outcomes:
Oral rinses, mouthwashes and sprays for improving recovery following tonsillectomy
1. Postoperative Hemorrhage 2. Analgesia 3. Pain
outcomes:
Steroids for idiopathic sudden sensorineural hearing loss
1. Psychosis 2. Hearing 3. Mood disturbance 4. Speech Finding 5. Death 6. Tinnitus 7. Avascular Necrosis Femoral Head 8. Glucose Intolerance 9. Gastrointestinal Bleeding 10. Audiometric Test
outcomes:
Acetaminophen (paracetamol) for the common cold in adults
1. Duration of Symptom 2. Visual Analog Scale 3. Cold Symptoms
outcomes:
Intranasal ipratropium bromide for the common cold
1. Rhinorrhea 2. Nasal Congestion 3. Global Assessment 4. Clinical Improvement
outcomes:
Antibiotics for the common cold and acute purulent rhinitis
1. Purulent Rhinitis 2. Common Cold
outcomes:
Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho‐pulmonary disease
1. Respiratory tract signs and symptoms 2. Clinical Resolution 3. Global Assessment 4. Time-to-Event 5. Clinical Improvement
outcomes:
Autoinflation for hearing loss associated with otitis media with effusion
1. Hearing 2. Tympanometry Testing 3. Audiogram
outcomes:
Interventions for the prevention of postoperative ear discharge after insertion of ventilation tubes (grommets) in children
1. Otorrhea
outcomes:
Surgery for Ménière's disease
1. Sensation Of Pressure In Ear 2. Hearing 3. Tinnitus 4. Vertigo
outcomes:
Clinical service organisation for adults with atrial fibrillation
1. Stroke 2. All Cause Mortality 3. Cerebellar Hemorrhage 4. Hospitalization 5. Haemorrhage 6. Transient Ischemia
outcomes:
Collaborative care approaches for people with severe mental illness
1. Quality of Life 2. Mental state 3. Death 4. Hospitalization 5. Psychiatric Commitment To Psychiatric Institution 6. Social functioning
outcomes:
Admission avoidance hospital at home
1. Costs and Cost Analysis 2. Hospital admission 3. Caregiver 4. Length Of Stay 5. Functional ability 6. Living In Residential Institution 7. Patient Satisfaction 8. Patient-Reported Outcome 9. Healthcare Professional 10. Health Services Utilization 11. Quality of Life 12. Death 13. Health Status
outcomes:
Primary‐level and community worker interventions for the prevention of mental disorders and the promotion of well‐being in low‐ and middle‐income countries
1. Mental disorder 2. Quality of Life 3. Adverse Event
outcomes:
Interventions to improve the appropriate use of polypharmacy for older people
1. START Criteria 2. STOPP Criteria 3. Hospital admission 4. Quality of Life 5. Medication Appropriateness Index
outcomes:
Interventions for the uptake of evidence‐based recommendations in acute stroke settings
1. Quality of care
outcomes:
Acute assessment services for patient flow assistance in hospital emergency departments
1. Length Of Stay 2. Death 3. Waiting time
outcomes:
Pharmacological, non‐invasive brain stimulation and psychological interventions, and their combination, for treating depression after stroke
1. Central Nervous System Finding 2. Withdrawn From Research Study 3. Functional Finding Of Gastrointestinal Tract 4. Neurological Finding 5. Depression 6. Death 7. Activities Of Daily Living Assessment
outcomes:
Case management for integrated care of older people with frailty in community settings
1. Change of residence 2. Serious Adverse Event 3. Quality of Life 4. Death 5. Living alone
outcomes:
Medication review in hospitalised patients to reduce morbidity and mortality
1. Death 2. Emergency room admission 3. Readmission 4. Health-Related Quality of Life
outcomes:
Comprehensive Geriatric Assessment for community‐dwelling, high‐risk, frail, older people
1. Serious Adverse Event 2. Nursing home admission 3. Hospital admission 4. Quality of Life 5. Death 6. Emergency room admission 7. Functional ability
outcomes:
Discharge planning from hospital
1. Costs and Cost Analysis 2. Health Status Index 3. Duration Of Hospital Stay 4. Hospitalization 5. Readmission 6. Patient Status
outcomes:
Early warning systems and rapid response systems for the prevention of patient deterioration on acute adult hospital wards
1. Admission to Intensive Care Unit 2. Cardiac Arrest 3. Respiratory Arrest 4. Length Of Stay 5. Death 6. Unexpected Death 7. Readmission
outcomes:
Routine provision of feedback from patient‐reported outcome measurements to healthcare providers and patients in clinical practice
1. Finding Of Health Perception, Health Management Pattern 2. Quality of Life 3. Fatigue 4. Patient-physician communication 5. Nausea 6. Functional ability 7. Psychological Symptom 8. Patient-Reported Outcome
outcomes:
Decision‐support tools via mobile devices to improve quality of care in primary healthcare settings
1. Time to care management 2. General well-being 3. Acceptability of treatment 4. Health Status 5. Patient-Reported Outcome
outcomes:
Telerehabilitation services for stroke
1. Upper Limb Function 2. Depression 3. Health-Related Quality of Life 4. Activities Of Daily Living Assessment 5. Self-care practice 6. Patient-Reported Outcome
outcomes:
Pharmacy‐based management for depression in adults
1. Withdrawn From Research Study 2. Patient-initiated Visit to General Practitioner 3. Quality of Life 4. Depression 5. Depressive symptoms 6. Medication adherence 7. Clinician-Reported Outcome 8. Social functioning 9. Clinical Improvement 10. Patient-Reported Outcome
outcomes:
Manually‐generated reminders delivered on paper: effects on professional practice and patient outcomes
1. Guidelines implementation 2. Healthcare delivery 3. Blood Pressure 4. Serum Cholesterol 5. Death 6. Pulmonary Embolism 7. Healthcare targets
outcomes:
Telephone counselling for smoking cessation
1. Smoking cessation
outcomes:
Follow‐up services for improving long‐term outcomes in intensive care unit (ICU) survivors
1. Cognitive function 2. All Cause Mortality 3. Recommendation To Return To Work 4. Posttraumatic Stress Disorder 5. Depression 6. Anxiety 7. Return to education 8. Physical Functional Dependency 9. Adverse Event 10. Health-Related Quality of Life
outcomes:
Patient‐mediated interventions to improve professional practice
1. Patient compliance 2. Patient Satisfaction
outcomes:
Impact of public release of performance data on the behaviour of healthcare consumers and providers
1. Professional performance 2. Staff morale 3. Death 4. Healthcare Decision Making 5. Adverse Event 6. Health Care Utilization 7. Performance data 8. Patient-Reported Outcome
outcomes:
Pharmacist services for non‐hospitalised patients
1. Adverse Drug Reaction 2. HbA1c level 3. Blood Pressure 4. Death 5. Hospitalization 6. Functional ability
outcomes:
Hospitalisation in short‐stay units for adults with internal medicine diseases and conditions
1. Activities of Daily Living 2. All Cause Mortality 3. Serious Adverse Event 4. Costs and Cost Analysis 5. Quality of Life 6. Readmission 7. Adverse Event
outcomes:
Nurses as substitutes for doctors in primary care
1. Costs and Cost Analysis 2. Quality of Life 3. Death 4. Health Status 5. Patient compliance 6. Patient Satisfaction
outcomes:
Improving adherence to Standard Precautions for the control of health care‐associated infections
1. Patient knowledge 2. Adherence to standard precautions 3. Mrsa Colonisation
outcomes:
Comprehensive geriatric assessment for older people admitted to a surgical service
1. Delirium 2. Costs and Cost Analysis 3. Level of care 4. Death 5. Complication 6. Hospitalization 7. Readmission
outcomes:
Patient reminder and recall interventions to improve immunization rates
1. Immunization 2. Reminding
outcomes:
Providing physicians with feedback on medication adherence for people with chronic diseases taking long‐term medication
1. Emergency Department Patient Visit 2. Medication adherence 3. Hospitalization 4. Oral Steroid Therapy 5. Outpatient Care Management 6. Aortoiliac Atherosclerosis 7. Patient-Reported Outcome 8. Side effects 9. HbA1c level 10. Communication skills 11. Measurement Of Serum Lipid Level 12. HIV infection 13. Viral load 14. Hypertensive disorder 15. Change Of Medication 16. Quality of care
outcomes:
Interventions to change the behaviour of health professionals and the organisation of care to promote weight reduction in children and adults with overweight or obesity
1. Body Mass Index 2. Healthcare costs 3. Body weight 4. Dissatisfaction With Body Image 5. Adverse Event 6. Health-Related Quality of Life
outcomes:
Comprehensive geriatric assessment for older adults admitted to hospital
1. Cognitive function 2. Living at home 3. Costs and Cost Analysis 4. Dependence 5. Death 6. Duration Of Hospital Stay 7. Living In Nursing Home
outcomes:
Interprofessional collaboration to improve professional practice and healthcare outcomes
1. Morbidity Index 2. Patient Satisfaction Score 3. Quality of Life 4. Death 5. Complication 6. Readmission 7. Disease Condition Finding 8. Functional ability 9. Patient compliance 10. Continuity Of Care Management
outcomes:
Home or foster home care versus institutional long‐term care for functionally dependent older people
1. Hospital admission 2. Quality of Life 3. Death 4. General Physical Finding 5. Adverse Event
outcomes:
Non‐medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care
1. HbA1c level 2. Systolic Blood Pressure 3. Hospitalization 4. Adverse Event 5. Health-Related Quality of Life 6. Patient Satisfaction 7. Low Density Lipoprotein Measurement
outcomes:
Tools developed and disseminated by guideline producers to promote the uptake of their guidelines
1. Guidelines implementation 2. Professional performance 3. Patient outcome 4. Healthcare resource use
outcomes:
Mobile clinics for women's and children's health
1. Costs and Cost Analysis 2. Health Services Utilization 3. Health-related Behavior Finding 4. Health Status 5. Patient Satisfaction
outcomes:
Integrated management of childhood illness (IMCI) strategy for children under five
1. Death 2. Nutritional status 3. Quality of care
outcomes:
Professional interventions for general practitioners on the management of musculoskeletal conditions
1. Employee absenteeism 2. Costs and Cost Analysis 3. Pain Scale 4. Bone densitometry 5. Drug Therapy 6. Health-related Behavior Finding 7. Hospitalization 8. Absenteeism 9. Musculoskeletal Symptom 10. Functional ability 11. Disability 12. Morbidity Index 13. Pain 14. Healthcare Professional 15. Quality of Life 16. Death 17. Referral To Service 18. Pain Control 19. Fracture 20. Health Care Utilization
outcomes:
Transition of care for adolescents from paediatric services to adult health services
1. Denyes Self Care Practice Instrument 2. Assessment Using Patient Activation Measure 3. General well-being 4. Health Services Utilization 5. Quality of Life 6. Patient-Reported Outcome
outcomes:
Interventions to optimise prescribing for older people in care homes
1. Costs and Cost Analysis 2. Hospital admission 3. Quality of Life 4. Death 5. Medication review 6. Adverse Event
outcomes:
Interactive telemedicine: effects on professional practice and health care outcomes
1. Quality Of Life Scale 2. All Cause Mortality 3. Costs and Cost Analysis 4. HbA1c level 5. Blood Pressure 6. Healthcare Supplies 7. Serum Ldl Cholesterol Measurement 8. Quality of Life 9. Death 10. Hospitalization 11. Adverse Event
outcomes:
Alternative versus standard packages of antenatal care for low‐risk pregnancy
1. Premature Delivery 2. Stillbirth 3. Pre-eclampsia
outcomes:
Medical day hospital care for older people versus alternative forms of care
1. Physical Activity Level 2. Death 3. Physical Functional Dependency
outcomes:
Chronic disease management programmes for adults with asthma
1. Smoking cessation 2. Emergency Department Patient Visit 3. Healthcare Professional 4. Client Participation 5. Prescribing 6. Patient 7. Hospitalization 8. Lost workdays 9. Asthma Action Care Planning 10. Symptom control therapy
outcomes:
In‐service training for health professionals to improve care of seriously ill newborns and children in low‐income countries
1. Professional performance 2. Death 3. Resuscitation
outcomes:
Case management approaches to home support for people with dementia
1. Cognitive function 2. Healthcare costs 3. Behavior 4. Quality of Life 5. Mood 6. Caregiver Role Strain 7. Death 8. Depression 9. Finding Relating To Institutionalization
outcomes:
Dental auxiliaries for dental care traditionally provided by dentists
1. Performance Feedback 2. Dental Pit/Fissure Sealant 3. Survival
outcomes:
Task shifting from doctors to non‐doctors for initiation and maintenance of antiretroviral therapy
1. Death 2. Quality of care
outcomes:
Computerized advice on drug dosage to improve prescribing practice
1. Side effects 2. Costs and Cost Analysis 3. Drug Concentration 4. Length Of Stay 5. Death 6. Monitoring Physiological Parameters 7. Drug toxicity 8. Clinical Improvement
outcomes:
Nutritional screening for improving professional practice for patient outcomes in hospital and primary care settings
1. Death 2. Health-Related Quality of Life 3. Morbidity
outcomes:
Managerial supervision to improve primary health care in low‐ and middle‐income countries
1. Job satisfaction 2. Patient knowledge 3. Performance score 4. Provider-specific Procedure 5. Patient Satisfaction
outcomes:
Dressings and topical agents containing hyaluronic acid for chronic wound healing
1. Wound Healing 2. Adverse Event
outcomes:
Anti‐vascular endothelial growth factor for diabetic macular oedema: a network meta‐analysis
1. Visual Acuity Testing 2. Retina Finding
outcomes:
Fenofibrate for diabetic retinopathy
1. Quality of Life 2. Adverse Event 3. Diabetic Retinopathy
outcomes:
Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or diabetes
1. Adverse Event 2. Walking ability
outcomes:
Anti‐vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy
1. Postoperative Complication 2. Vitreous Hemorrhage 3. Retinal Detachment 4. Visual Acuity Testing 5. Quality of Life 6. Rubeosis Iridis
outcomes:
Blood pressure control for diabetic retinopathy
1. Proliferative Diabetic Retinopathy 2. Visual Acuity Testing 3. Nonproliferative Diabetic Retinopathy
outcomes:
Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy
1. Visual Acuity
outcomes:
Parathyroidectomy for adults with primary hyperparathyroidism
1. Clinical Cure 2. Adverse Event
outcomes:
Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes
1. High Birth Weight 2. Stillbirth 3. Neonatal morbidity 4. Gestational Diabetes Mellitus 5. Neonatal Death 6. Hypertensive disorder
outcomes:
Pharmacological interventions for prevention of weight gain in people with schizophrenia
1. Withdrawn From Research Study 2. Body weight 3. Nausea
outcomes:
Rituximab for thyroid‐associated ophthalmopathy
1. Thyroid Eye Disease
outcomes:
Recombinant human thyrotropin (rhTSH)‐aided radioiodine treatment for non‐toxic multinodular goitre
1. Quality of Life 2. Death 3. Hypothyroidism 4. Adverse Event 5. Thyroid volume
outcomes:
Through‐knee versus above‐knee amputation for vascular and non‐vascular major lower limb amputations
1. Fitting Of Lower Limb Prosthesis 2. Primary wound healing 3. Wound Healing
outcomes:
Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes
1. Quality of Life 2. Adverse Event
outcomes:
Nutritional supplementation for nonalcohol‐related fatty liver disease: a network meta‐analysis
1. Antioxidants 2. Probiotics 3. All Cause Mortality 4. Serious Adverse Event 5. Vitamin E 6. Vitamin D and analogues 7. Amino acids I.V. solution additives 8. Synbiotics 9. Health-Related Quality of Life 10. Prebiotics
outcomes:
Lifestyle modifications for nonalcohol‐related fatty liver disease: a network meta‐analysis
1. All Cause Mortality 2. Serious Adverse Event 3. Health-Related Quality of Life
outcomes:
Interventions for weight loss in people with chronic kidney disease who are overweight or obese
1. Cardiovascular Event 2. Death 3. Body Measurements
outcomes:
Interventions for preventing type 2 diabetes in adults with mental disorders in low‐ and middle‐income countries
1. Body Mass Index 2. Withdrawn From Research Study 3. Fasting 4. Diabetes Mellitus
outcomes:
Psychological interventions for treating foot ulcers, and preventing their recurrence, in people with diabetes
1. Disease Recurrence 2. Wound Healing 3. Diabetic Foot Ulcer
outcomes:
Antiandrogen or estradiol treatment or both during hormone therapy in transitioning transgender women
1. Sexual Satisfaction Scale for Women 2. Serious Adverse Event 3. Quality of Life Inventory 4. Quality of Life 5. Body Image Quality of Life Inventory 6. Hormone Replacement Therapy 7. Patient Satisfaction
outcomes:
Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
1. Intermediate hyperglycemia 2. All Cause Mortality 3. Serious Adverse Event 4. Type 2 Diabetes Mellitus 5. Lifestyle changes
outcomes:
(Ultra‐)long‐acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus
1. Stroke 2. Retinopathy 3. Diabetes Mellitus 4. Hypoglycemia 5. Adverse Event 6. Health-Related Quality of Life 7. End Stage Kidney Disease 8. Myocardial Infarction 9. HbA1c level 10. Serious Adverse Event 11. Amputation 12. Complication 13. Treatment discontinued
outcomes:
Minimally invasive parathyroidectomy guided by intraoperative parathyroid hormone monitoring (IOPTH) and preoperative imaging versus bilateral neck exploration for primary hyperparathyroidism in adults
1. All Cause Mortality 2. Treatment Success 3. Duration Of Surgery 4. Duration Of Hospital Stay 5. Adverse Event 6. Health-Related Quality of Life 7. Patient Satisfaction
outcomes:
Nutritional interventions for treating foot ulcers in people with diabetes
1. Foot Ulcer 2. Amputation 3. Quality of Life 4. Healing 5. Death 6. Ulcer
outcomes:
Metformin monotherapy for adults with type 2 diabetes mellitus
1. All Cause Mortality 2. Serious Adverse Event 3. Health-Related Quality of Life
outcomes:
Non‐nutritive sweeteners for diabetes mellitus
1. HbA1c level 2. Body weight 3. Adverse Event
outcomes:
Zinc supplementation for the promotion of growth and prevention of infections in infants less than six months of age
1. Infant Death 2. Growth 3. Body weight 4. Underweight 5. Nutritional Wasting 6. Head Circumference 7. Diarrhoea 8. Height and growth measurements 9. Nutritional Stunting
outcomes:
Resveratrol for adults with type 2 diabetes mellitus
1. All Cause Mortality 2. HbA1c level 3. Adverse Event 4. Diabetic Complication 5. Health-Related Quality of Life
outcomes:
Metformin for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
1. All Cause Mortality 2. Serious Adverse Event 3. Type 2 Diabetes Mellitus 4. Incidence
outcomes:
Oxandrolone for growth hormone‐treated girls aged up to 18 years with Turner syndrome
1. All Cause Mortality 2. General Finding Of Height 3. Wechsler Intelligence Scale for Children-Revised 4. Vocal frequency 5. Adverse Event 6. Health-Related Quality of Life
outcomes:
Thyroxine replacement for subfertile women with euthyroid autoimmune thyroid disease or subclinical hypothyroidism
1. Live Birth 2. Complication Of Pregnancy 3. Miscarriage
outcomes:
Techniques of monitoring blood glucose during pregnancy for women with pre‐existing diabetes
1. Infant Death 2. Pregnancy-induced Hypertension 3. Stillbirth 4. Large For Gestational Age 5. Neonatal Death 6. Perinatal Death 7. Pre-eclampsia 8. Pregnancy Associated Hypertension 9. Glycaemia Control 10. Sensory Disability 11. Cesarean Section 12. Premature Delivery 13. Morbidity Index 14. HbA1c level 15. Blood glucose measurement 16. Hypertension Associated Disorders Of Pregnancy
outcomes:
Metformin and second‐ or third‐generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
1. All Cause Mortality 2. Stroke 3. Myocardial Infarction 4. Serious Adverse Event 5. Cardiovascular Mortality 6. Health-Related Quality of Life
outcomes:
Transperitoneal versus retroperitoneal laparoscopic adrenalectomy for adrenal tumours in adults
1. All Cause Mortality 2. Costs and Cost Analysis
outcomes:
Alpha‐glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
1. Stroke 2. Myocardial Infarction 3. All Cause Mortality 4. Congestive Heart Failure 5. Serious Adverse Event 6. Costs and Cost Analysis 7. Type 2 Diabetes Mellitus 8. Cardiovascular Mortality
outcomes:
Sliding scale insulin for non‐critically ill hospitalised adults with diabetes mellitus
1. Postoperative Complication 2. All Cause Mortality 3. Costs and Cost Analysis 4. Hypoglycemic episode 5. Death 6. Hospitalization 7. Blood glucose measurement
outcomes:
Tocilizumab for thyroid eye disease
1. Relapse 2. Disease Progression 3. Compressive Optic Neuropathy Due To Thyroid Eye Disease 4. Limited Ocular Motility 5. Quality of Life 6. Adverse Event
outcomes:
Negative pressure wound therapy for treating foot wounds in people with diabetes mellitus
1. Costs and Cost Analysis 2. Disease Recurrence 3. Wound observation 4. Surgery 5. Wound Healing 6. Foot amputation 7. Adverse Event 8. Wound 9. Time-to-Event
outcomes:
Monotherapy laser photocoagulation for diabetic macular oedema
1. Visual Acuity Testing 2. Quality of Life 3. Retinal Thickening
outcomes:
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes
1. Pregnancy Associated Hypertension 2. Birth Weight 3. Large For Gestational Age 4. Gestational Diabetes Mellitus 5. Diarrhoea 6. Pre-eclampsia 7. Weight Gain
outcomes:
Anti‐vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema
1. Optical Coherence Tomography Of Retina 2. Cataract 3. Uveitis 4. Visual Acuity Testing 5. Quality of Life 6. Raised Intraocular Pressure 7. Adverse Event 8. Retinal Thickening
outcomes:
Different lasers and techniques for proliferative diabetic retinopathy
1. Proliferative Diabetic Retinopathy 2. Visual Acuity Testing 3. Treatment Pain 4. Adverse Event
outcomes:
Planned birth at or near term for improving health outcomes for pregnant women with pre‐existing diabetes and their infants
1. Delivery By Vacuum Extraction 2. Cesarean Section 3. Shoulder Dystocia 4. Forceps Delivery 5. Morbidity Index 6. Stillbirth 7. Large For Gestational Age 8. Death 9. Neonatal Death 10. Perinatal Death 11. Vaginal Delivery 12. Acidemia
outcomes:
Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus
1. All Cause Mortality 2. Stroke 3. Myocardial Infarction 4. Costs and Cost Analysis 5. Serious Adverse Event 6. Type 2 Diabetes Mellitus 7. Cardiovascular Mortality 8. Health-Related Quality of Life
outcomes:
Insulin for the treatment of women with gestational diabetes
1. Infant Death 2. Pregnancy-induced Hypertension 3. Hearing impairment 4. Body weight 5. Visual Impairment 6. Large For Gestational Age 7. Postpartum Depression 8. Developmental Delay 9. Neonatal Hypoglycemia 10. Induction Of Labor 11. Perinatal Death 12. Neonatal Death 13. Pre-eclampsia 14. Diabetes Mellitus 15. Adipositas 16. Perineal injury 17. Sensory Disability 18. Cesarean Section 19. Morbidity Index 20. Fetal Death 21. Type 2 Diabetes Mellitus 22. Eclampsia 23. Death 24. Hypertension Associated Disorders Of Pregnancy
outcomes:
Oral anti‐diabetic agents for women with established diabetes/impaired glucose tolerance or previous gestational diabetes planning pregnancy, or pregnant women with pre‐existing diabetes
1. Pregnancy-induced Hypertension 2. Body weight 3. Stillbirth 4. Postpartum Depression 5. Large For Gestational Age 6. Induction Of Labor 7. Neonatal Death 8. Perinatal Death 9. Pre-eclampsia 10. Diabetes Mellitus 11. Hypoglycemia 12. Adipositas 13. Perineal injury 14. Cesarean Section 15. Sensory Disability 16. Morbidity Index 17. Hypertension Associated Disorders Of Pregnancy
outcomes:
Psychological interventions for diabetes‐related distress in adults with type 2 diabetes mellitus
1. Self Efficacy 2. All Cause Mortality 3. HbA1c level 4. Distress 5. Adverse Event 6. Health-Related Quality of Life
outcomes:
Preconception care for diabetic women for improving maternal and infant health
1. Infant Death 2. Cardiovascular finding 3. Stillbirth 4. Large For Gestational Age 5. Induction Of Labor 6. Neonatal Death 7. Perinatal Death 8. Diabetes Mellitus 9. Adipositas 10. Perineal injury 11. Congenital Malformation 12. Sensory Disability 13. Cesarean Section 14. Morbidity Index 15. Pregnancy 16. Weight Gain 17. Hypertension Associated Disorders Of Pregnancy
outcomes:
Phototherapy for treating foot ulcers in people with diabetes
1. Wound Healing 2. Adverse Event
outcomes:
Topical antimicrobial agents for treating foot ulcers in people with diabetes
1. Wound Healing 2. Adverse Event 3. Wound Infection
outcomes:
Glucose targets for preventing diabetic kidney disease and its progression
1. End Stage Kidney Disease 2. Stroke 3. Myocardial Infarction 4. All Cause Mortality 5. Disease Progression 6. Death 7. Sudden Death 8. Cardiovascular Mortality 9. Increased Serum Creatinine 10. Microalbuminuria
outcomes:
Dipeptidyl‐peptidase (DPP)‐4 inhibitors and glucagon‐like peptide (GLP)‐1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus
1. All Cause Mortality 2. Stroke 3. Myocardial Infarction 4. Congestive Heart Failure 5. Serious Adverse Event 6. Costs and Cost Analysis 7. Type 2 Diabetes Mellitus 8. Cardiovascular Mortality 9. Health-Related Quality of Life
outcomes:
Lifestyle interventions for the treatment of women with gestational diabetes
1. Infant Death 2. Body weight 3. Postpartum Depression 4. Large For Gestational Age 5. Neonatal Hypoglycemia 6. Induction Of Labor 7. Perinatal Death 8. Neonatal Death 9. Pre-eclampsia 10. Adipositas 11. Perineal injury 12. Sensory Disability 13. Cesarean Section 14. Morbidity Index 15. Fetal Death 16. Type 2 Diabetes Mellitus 17. Hypertension Associated Disorders Of Pregnancy
outcomes:
Supportive interventions for enhancing dietary intake in malnourished or nutritionally at‐risk adults
1. Institutionalized 2. Morbidity Index 3. Dietary Intake Finding 4. Hospitalization 5. Adverse Event 6. Health-Related Quality of Life 7. Nutritional status
outcomes:
Drug interventions for the treatment of obesity in children and adolescents
1. Body Mass Index 2. All Cause Mortality 3. Costs and Cost Analysis 4. Morbidity Index 5. Assessment Using Bmi (body Mass Index) 6. Adverse Event 7. Health-Related Quality of Life
outcomes:
Insulin secretagogues for prevention or delay of type 2 diabetes mellitus and its associated complications in persons at increased risk for the development of type 2 diabetes mellitus
1. All Cause Mortality 2. Stroke 3. Myocardial Infarction 4. Serious Adverse Event 5. Congestive Heart Failure 6. Costs and Cost Analysis 7. Type 2 Diabetes Mellitus 8. Cardiovascular Mortality 9. Health-Related Quality of Life
outcomes:
Short‐acting insulin analogues versus regular human insulin for adults with type 1 diabetes mellitus
1. All Cause Mortality 2. HbA1c level 3. Severe Hypoglycemic Event
outcomes:
Fortification of staple foods with zinc for improving zinc status and other health outcomes in the general population
1. Serum Zinc 2. Zinc Deficiency 3. Underweight 4. Nutritional Stunting
outcomes:
Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes
1. Cesarean Section 2. Stillbirth 3. Large For Gestational Age 4. Neonatal Death 5. Diabetes Mellitus 6. Hypertensive disorder
outcomes:
Autologous platelet‐rich plasma for treating chronic wounds
1. Chronic Wound 2. Wound Healing 3. Adverse Event
outcomes:
Different intensities of glycaemic control for pregnant women with pre‐existing diabetes
1. Fetal Death 2. Neonatal morbidity 3. Neonatal Death 4. Pre-eclampsia 5. Birth 6. Congenital Malformation
outcomes:
Self management interventions for type 2 diabetes in adult people with severe mental illness
1. Diabetic Complications NEC 2. All Cause Mortality 3. Costs and Cost Analysis 4. HbA1c level 5. Self-care Behavior 6. Adverse Event 7. Health-Related Quality of Life
outcomes:
Sodium‐glucose cotransporter (SGLT) 2 inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus
1. All Cause Mortality 2. Serious Adverse Event 3. Type 2 Diabetes Mellitus
outcomes:
Radioiodine therapy versus antithyroid medications for Graves' disease
1. Costs and Cost Analysis 2. Hyperthyroidism 3. Finding Of Thyroid Function 4. Thyroid Eye Disease 5. Adverse Event 6. Health-Related Quality of Life
outcomes:
Skin grafting and tissue replacement for treating foot ulcers in people with diabetes
1. Wound Healing 2. Diabetic Foot Ulcer 3. Limb amputation
outcomes:
Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis
1. All Cause Mortality 2. Morbidity Index 3. Hypoglycemic event 4. Hospitalization 5. Adverse Event 6. Patient Satisfaction
outcomes:
Intensive versus conventional glycaemic control for treating diabetic foot ulcers
1. Foot amputation 2. Diabetic Foot Ulcer
outcomes:
Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years
1. Body Mass Index 2. All Cause Mortality 3. Morbidity Index 4. Costs and Cost Analysis 5. Weight change 6. Role Relationship Pattern 7. Adverse Event 8. Health-Related Quality of Life
outcomes:
Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy
1. Costs and Cost Analysis 2. Hyperthyroidism 3. Hypoparathyroidism 4. Thyroid Eye Disease 5. Adverse Event 6. Hypocalcemia
outcomes:
Growth factors for treating diabetic foot ulcers
1. Quality of Life 2. Wound Healing 3. Diabetic Foot Ulcer 4. Adverse Event 5. Limb amputation
outcomes:
Aromatase inhibitors for short stature in male children and adolescents
1. Cognitive function 2. General Finding Of Height 3. Costs and Cost Analysis 4. Adverse Event 5. Health-Related Quality of Life
outcomes:
Systemic antibiotics for treating diabetic foot infections
1. Infection 2. Complication 3. Adverse Event 4. Infection Of Foot Associated With Diabetes 5. Therapeutic Response
outcomes:
Complex interventions for preventing diabetic foot ulceration
1. Foot amputation 2. Diabetic Foot Ulcer
outcomes:
Total or near‐total thyroidectomy versus subtotal thyroidectomy for multinodular non‐toxic goitre in adults
1. All Cause Mortality 2. Costs and Cost Analysis 3. Disease Recurrence 4. Thyroid Cancer 5. Hypoparathyroidism 6. Health-Related Quality of Life
outcomes:
Hyperbaric oxygen therapy for chronic wounds
1. Pressure ulcer 2. Ulcer 3. Diabetic ulcer 4. Wound Healing 5. Venous leg ulcer 6. Limb amputation
outcomes:
Topical non‐steroidal anti‐inflammatory agents for diabetic cystoid macular oedema
1. Visual Acuity Testing
outcomes:
Calcimimetics for secondary hyperparathyroidism in chronic kidney disease patients
1. All Cause Mortality 2. Cardiovascular Mortality 3. Nausea 4. Parathyroidectomy 5. Fracture 6. Adverse Event 7. Hypocalcemia
outcomes:
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
1. Kidney disease 2. All Cause Mortality 3. Retinopathy 4. HbA1c level 5. Costs and Cost Analysis 6. Ketoacidosis 7. Neuropathy 8. Severe Hypoglycemic Event 9. Health-Related Quality of Life
outcomes:
Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults
1. Relapse 2. Costs and Cost Analysis 3. Diet 4. Body weight 5. Physical Activity Level 6. Health-Related Quality of Life
outcomes:
Vitamin D supplementation for prevention of mortality in adults
1. All Cause Mortality 2. Cardiovascular observations 3. Costs and Cost Analysis 4. Adverse Event 5. Cancer
outcomes:
Blue‐light filtering spectacle lenses for visual performance, sleep, and macular health in adults
1. Critical fusion frequency 2. Eyes and vision 3. Fatigue
outcomes:
Laser‐assisted cataract surgery versus standard ultrasound phacoemulsification cataract surgery
1. Postoperative Complication 2. Intraoperative Complications 3. Measuring Patient-Reported Outcomes 4. Visual Acuity Testing 5. Cystoid Macular Edema
outcomes:
Antibiotics versus placebo for acute bacterial conjunctivitis
1. Bacterial Conjunctivitis
outcomes:
Device‐modified trabeculectomy for glaucoma
1. Hypotony Of Eye 2. Visual Acuity Testing 3. Intraocular Pressure Test
outcomes:
Lens extraction versus laser peripheral iridotomy for acute primary angle closure
1. Intraocular pressure
outcomes:
Interventions for acute non‐arteritic central retinal artery occlusion
1. Best-corrected visual acuity
outcomes:
Trifocal intraocular lenses versus bifocal intraocular lenses after cataract extraction among participants with presbyopia
1. Visual Acuity Testing 2. Quality of Life 3. Contrast Sensitivity Test 4. Adverse Event
outcomes:
Iridotomy to slow progression of visual field loss in angle‐closure glaucoma
1. Gonioscopy With Evaluation 2. Medication Dose Changed 3. Visual Field Defect 4. Quality of Life 5. Intraocular Pressure Test 6. Adverse Event
outcomes:
Early vitrectomy for exogenous endophthalmitis following surgery
1. Visual Acuity Testing
outcomes:
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure
1. Endophthalmitis
outcomes:
Tocilizumab for giant cell arteritis
1. Disease Condition Determination, Well Controlled
outcomes:
Immediate sequential bilateral surgery versus delayed sequential bilateral surgery for cataracts
1. Costs and Cost Analysis 2. Visual Acuity 3. Refraction Assessment 4. Endophthalmitis 5. Complication 6. Patient-Reported Outcome
outcomes:
Topical pharmacologic interventions versus placebo for epidemic keratoconjunctivitis
1. Disease Condition Determination, Cured 2. Adverse Event
outcomes:
Pneumatic retinopexy versus scleral buckle for repairing simple rhegmatogenous retinal detachments
1. Reattachment Of Choroid And Retina
outcomes:
Fornix‐based versus limbal‐based conjunctival trabeculectomy flaps for glaucoma
1. Treatment Failure 2. Visual Acuity Testing 3. Quality of Life 4. Intraocular Pressure Test 5. Medication dose increased
outcomes:
Intraocular lens optic edge design for the prevention of posterior capsule opacification after cataract surgery
1. Posterior Capsule Opacification 2. Visual Acuity Testing 3. Quality of Life 4. Adverse Event 5. Capsulotomy Of Lens
outcomes:
Adjunctive modulation of wound healing during cataract surgery to promote survival of a previous trabeculectomy
1. Surgical complication 2. Failed Filtering Bleb
outcomes:
Photobiomodulation for non‐exudative age‐related macular degeneration
1. Visual Acuity Testing 2. Quality of Life 3. Contrast Sensitivity Test